A feasibility study of sequential carboplatin followed by paclitaxel/gemcitabine as first line chemotherapy for stage Ic-IV ovarian, fallopian tube and primary peritoneal carcinomas.

Trial Profile

A feasibility study of sequential carboplatin followed by paclitaxel/gemcitabine as first line chemotherapy for stage Ic-IV ovarian, fallopian tube and primary peritoneal carcinomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Carboplatin; Paclitaxel
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Adverse reactions
  • Acronyms SCOTROC-5
  • Most Recent Events

    • 30 Jan 2014 Status changed from active, no longer recruiting to completed as per United Kingdom Clinical Research Network.
    • 07 Apr 2009 Additional lead trial centres identified as reported by United Kingdom Clinical Research Network.
    • 07 Apr 2009 Additional lead trial investigator identified as Kaye S as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top